Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm
NCT06707051
Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin (TXA)
Comparison of Efficacy of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin
Sponsor: District Headquarters Teaching Hospital Sahiwal
Conditions
Abormal utèrine Bleeding Agranulocytosis Bleeding Bleeding Pattern Endometrial Endometrial Bleeding GI Disturbance Heavy. Mentrual Bleeding Hypersensitivity Response Uterine Bleeding
Interventions
Calcium dobesilate (Doxium) Tranexamic Acid
Updated 1 time since 2024 Last updated: Nov 26, 2024 Started: Jan 1, 2022 Primary completion: Dec 31, 2023 Completion: Jun 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06707051, this PHASE2/PHASE3 trial focuses on Abormal utèrine Bleeding and Agranulocytosis and remains completed. Sponsored by District Headquarters Teaching Hospital Sahiwal, it has been updated 1 time since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE2/PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- District Headquarters Teaching Hospital Sahiwal
Data source: District Headquarters Teaching Hospital Sahiwal
For direct contact, visit the study record on ClinicalTrials.gov .